Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/29/2025 1:23:52 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1831
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
Boatbuilder
08/07/2025 8:40:31 AM
Yeah, I make a killing day trading a
(2)
My69z
08/07/2025 7:30:37 AM
& Rogex broke down those that were in
(7)
KenChowder
08/07/2025 6:53:15 AM
Here's another paper that supports the
(8)
My69z
08/07/2025 5:35:06 AM
From 2020 with Pestell -- " In analysis
(7)
My69z
08/07/2025 5:19:39 AM
"For example, CCR5 is overexpressed in
(8)
KenChowder
08/07/2025 4:29:18 AM
Not sure Mr./Ms. Rug's figures are
(7)
Niele
08/07/2025 3:31:50 AM
Posted by Artsakh_Rug on Reddit.
(9)
My69z
08/07/2025 12:43:30 AM
Don't let it fade away how fortunate an
(18)
My69z
08/06/2025 9:59:40 PM
My bet based on Our Science: Will
(6)
ohm20
08/06/2025 9:38:23 PM
I just wonder if our new FDA - if they
(16)
USS JOHNSTON
08/06/2025 9:06:38 PM
Thanks, brentie. Question: Is it
(8)
Figgs
08/06/2025 8:36:41 PM
But a scam is two way street, so
(3)
ohm20
08/06/2025 7:32:47 PM
I have come to the conclusion that
(17)
sean007
08/06/2025 7:14:54 PM
This appears to be an excellent window
(6)
sean007
08/06/2025 5:21:41 PM
Occam's razor to the
(1)
Figgs
08/06/2025 5:13:39 PM
So if nobody knows anything, why are
(7)
Evil Rabbit
08/06/2025 4:35:55 PM
Plus a generous seasoning of
(7)
brentie
08/06/2025 4:32:57 PM
Top 5 Pharma Startups Tackling Sexually
(10)
Boatbuilder
08/06/2025 4:27:32 PM
Not really, its just the simplest
(2)
sean007
08/06/2025 3:43:11 PM
..."IF patients are progressing in (the
(1)
FKAdamF.
08/06/2025 2:51:55 PM
A very appropriate response after the
(3)
Camp2800
08/06/2025 2:49:55 PM
Leronlimab - Merck Could Merck be slow
(3)
MidnightRider
08/06/2025 2:40:58 PM
Can't we all just get
(4)
Evil Rabbit
08/06/2025 12:50:50 PM
Nobody here knows anything. Theres
(7)
Katangolo
08/06/2025 12:47:44 PM
Cool. Im done. Ill go silent and
(1)
Katangolo
08/06/2025 12:47:09 PM
Sorry Ken, youre right. Siri cant
(1)
Boatbuilder
08/06/2025 12:33:03 PM
Nobody here knows anything. We are all
(10)
skezan
08/06/2025 11:34:26 AM
Groundhog Day again.
(1)
weasel667
08/06/2025 10:25:44 AM
Hey guys, what's with all the cryptic
(9)
docj
08/06/2025 10:24:05 AM
Yeah, I don't get it. All this is way
(6)
hoops
08/06/2025 7:28:22 AM
Hey guys, what's with all the cryptic
(24)
KenChowder
08/06/2025 3:39:11 AM
Expecting one very soon and please
(7)
Katangolo
08/06/2025 1:42:30 AM
Im on it, Shelly. Thanks for lurking
Shelly2626
08/05/2025 10:32:23 PM
Ok ....its time to get a big boom GLTA
(5)
Buddyboy20
08/05/2025 9:49:07 PM
Have Japanese researchers stumbled on a
(2)
brentie
08/05/2025 9:19:54 PM
Thanks for posting that, docj. I was
(16)
docj
08/05/2025 3:52:26 PM
https://d1io3yog0oux5.cloudfront.net/_c
(13)
My69z
08/05/2025 10:19:11 AM
"2nd opinion" ---- Imagine having been
(4)
My69z
08/05/2025 9:51:54 AM
"....we are excited to explore
(7)
My69z
08/05/2025 9:45:41 AM
& inventory into LL is what the recent
(1)
Katangolo
08/05/2025 9:23:46 AM
We were also told several years ago
(5)
hoops
08/05/2025 8:26:52 AM
Has this been posted previously? Has
(3)
Mr3Putt
08/05/2025 8:21:50 AM
Whilst we await whatever the bioscience
(5)
My69z
08/04/2025 7:31:31 PM
"The decline in circulating tumor cells
(17)
My69z
08/04/2025 7:10:20 PM
Science updated:
(16)
Mr3Putt
08/04/2025 3:02:10 PM
UWS on the murkiness of Merck:
(1)
rodolfo
08/04/2025 2:45:16 PM
The german H.Q. is in Darmstadt and in
(2)
Evil Rabbit
08/04/2025 12:55:20 PM
Well, if we've had an arrangement with
(5)
Ganesha
08/04/2025 12:31:50 PM
Well, if we've had an arrangement with
(17)
BuckCYDYLong
08/03/2025 10:30:44 AM
"Merck is investing heavily in its
Newer
Older
Recent Articles
Electrolux Group Reports Positive Growth in Q3 2025 Results
Flow Traders Reports 3Q 2025 Results with Insights
Key Advantages of Cross-Straits Development for Unity
Electrolux Group Reports Strong Q3 Performance in 2025
Aker Horizons ASA Unveils Key Financials for Q3 2025
Electrolux Group Reports Strong Q3 Performance and Future Plans
Hikvision Launches Innovative AI Solutions to Support SMBs Growth
Revolutionizing AI Podcasts: The Soul App's New Voice Model
General Motors' Workforce Reductions and EV Market Challenges
Nobu Hospitality Expands Global Presence with Luxury Residences
United Imaging Healthcare Sees Growth in Q3 2025 Revenue
ING Achieves Impressive Results with €1.787 Billion Profit
Clariant Reports Growth in Q3 2025 EBITDA Margin Amid Challenges
Arcadis Q3 2025 Growth and Margin Expansion Overview
dsm-firmenich Delivers Promising Q3 2025 Update Insights
Pluxee Celebrates Strong Financial Performance for Fiscal 2025
Hansa Biopharma's Major Milestones and Financial Insights
Hansa Biopharma's Q3 Success and Future Growth Plans
Hansa Biopharma Shows Positive Progress with Imlifidase Trials
ING's Successful Share Buyback and New €1.6 Billion Plan
argenx Achieves Significant Milestones in Q3 2025
ING's Major Buyback and New Shareholder Distribution Plan
Jim Cramer Advocates Sharing Nvidia's Advanced Chips with China
Exploring the Expanding Horizons of Sustainable Materials Growth
The Future of Main Landing Gears Market and Industry Insights
Idorsia Reports Impressive Growth in QUVIVIQ Sales and Financials
argenx Excels with Strong Third Quarter Performance and Plans
Scatec Updates on Third Quarter Performance and Future Plans
PixVerse Partners with UNU Network to Promote AI for Good
United Imaging Healthcare's Revenue Growth Spikes in Q3 2025
Roche's Strategic Acquisition of 89bio: Making Waves in Biopharma
Nobu Hospitality Launches Exquisite Residences and Dining in Kuwait
Pluxee Announces Impressive Fiscal 2025 Performance Highlights
Pulsar Helium's Jetstream #3 Well Reaches Major Milestone
Arcadis Reports Q3 2025 Growth With Expanding Margins
Ontex's Q3 Results Show Strong Progress Despite Market Challenges
dsm-firmenich Reports Encouraging Q3 2025 Performance Insights
Clariant Reports Growth in EBITDA Margin amidst Challenges
EfTEN Real Estate Fund's Positive Growth Trajectory Unveiled
Telenor's Nordic Security Report Highlights Urgent Cyber Threats
TGS ASA Announces Ex-Dividend Trading at NOK 1.56 Today
Crédit Agricole S.A. Reports Strong Q3 and 9M 2025 Earnings
ING Reports Impressive €1.787 Billion Net Income for 2025 Q3
AI Computing Power: A Sustainable Solution for Retirement
Innovative Sugar Reduction Solutions Unveiled by Samyang Corp
Societe Generale Shows Impressive Financial Growth in Q3 2025
FMC Corporation Faces Significant Stock Decline After Earnings Report
Piramal Pharma Solutions Forms New Alliance with IntoCell
Piramal Pharma and IntoCell Collaborate for Advanced Bioconjugates
AI Computing Power: A Solution for America’s Retirement Dilemma